Cardiovascular Risk Stratification by Automatic Coronary Artery Calcium Scoring on Pretreatment Chest Computed Tomography in Diffuse Large B-Cell Lymphoma Receiving Anthracycline-Based Chemotherapy: A Multicenter Study
Hesong ShenYanbang LianJinxue YinMinghong ZhuChun YangChunrong TuYangling PengXiaoqin LiJiuquan ZhangDepartment of Radiology,Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital,China (H.S.,C.T.,Y.P.,X.L.,J.Z.).Department of Radiology,The First Affiliated Hospital of Zhengzhou University,China (Y.L.).Department of Medical Imaging,Affiliated Cancer Hospital and Institute of Guangzhou Medical University,China (J.Y.).Department of Radiology,Chongqing University Fuling Hospital,China (M.Z.,C.Y.).
DOI: https://doi.org/10.1161/CIRCIMAGING.122.014829
2023-02-08
Abstract:Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Balancing the cardiovascular risk and benefit of anthracycline-based chemotherapy in patients with diffuse large B-cell lymphoma is an important clinical issue. We aimed to evaluate whether the pretreatment coronary artery calcium score (CACS) can stratify the risk of cancer therapy-related cardiac dysfunction (CTRCD) and major adverse cardiovascular events (MACEs) in patients with diffuse large B-cell lymphoma receiving anthracycline-based chemotherapy.METHODS:The patients with diffuse large B-cell lymphoma from 4 hospitals were retrospectively enrolled. The CACS was automatically calculated on nongated chest computed tomography before treatment using artificial intelligence-CACS software and divided into 3 categories (0, 1–100, and >100). The associations between the CACS and CTRCD and between the CACS and MACEs were assessed by logistic regression and Fine-Gray competing-risk regression model. Nelson–Aalen cumulative risk curve was performed to assess the cumulative incidence of MACEs.RESULTS:A total of 1468 patients (785 men and 683 women; 100% Asian) were enrolled, and 362 and 185 patients developed CTRCD and MACEs, respectively. Compared with a CACS of 0 (n=826), there was stepwise higher odds of CTRCD with a CACS between 1 and 100 (n=356; odds ratio, 2.587) and a CACS >100 (n=286; odds ratio, 5.239). The CACS was associated with MACEs (1–100 versus 0: subdistribution hazard ratio 3.726; >100 versus 0: subdistribution hazard ratio 7.858; allP 100 were 1.21%, 8.43%, and 11.19%, respectively, at 3 years, and 3.27%, 16.01%, 31.12%, respectively, at 5 years.CONCLUSIONS:The automatic CACS derived from chest computed tomography before treatment was helpful to identify high-risk patients of CTRCD and MACE and guide clinicians to implement cardiovascular protection strategies in patients with diffuse large B-cell lymphoma who received anthracycline-based chemotherapy.
radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems